How Many Monte Carlo Samples Are Needed for Probabilistic Cost-Effectiveness Analyses?

被引:0
|
作者
Yaesoubi, Reza [1 ,2 ]
机构
[1] Yale Sch Publ Hlth, Dept Hlth Policy & Management, New Haven, CT 06510 USA
[2] Yale Sch Publ Hlth, Publ Hlth Modeling Unit, New Haven, CT USA
关键词
cost-effectiveness analysis; Monte Carlo; probabilistic sensitivity analysis; sample size; CONFIDENCE-INTERVALS; EFFECTIVENESS RATIOS; SENSITIVITY-ANALYSIS; UNCERTAINTY ANALYSIS; MODELS;
D O I
暂无
中图分类号
F [经济];
学科分类号
02 ;
摘要
Objectives: Probabilistic sensitivity analysis (PSA) is conducted to account for the uncertainty in cost and effect of decision options under consideration. PSA involves obtaining a large sample of input parameter values (N) to estimate the expected cost and effect of each alternative in the presence of parameter uncertainty. When the analysis involves using stochastic models (eg, individual-level models), the model is further replicated P times for each sampled parameter set. We study how N and P should be determined. Methods: We show that PSA could be structured such that P can be an arbitrary number (say, P = 1). To determine N , we derive a formula based on Chebyshev's inequality such that the error in estimating the incremental cost-effectiveness ratio (ICER) of alternatives (or equivalently, the willingness-to-pay value at which the optimal decision option changes) is within a desired level of accuracy. We described 2 methods to confirm, visually and quantitatively, that the N informed by this method results in ICER estimates within the specified level of accuracy. Results: When N is arbitrarily selected, the estimated ICERs could be substantially different from the true ICER (even as P increases), which could lead to misleading conclusions. Using a simple resource allocation model, we demonstrate that the proposed approach can minimize the potential for this error. Conclusions: The number of parameter samples in probabilistic cost-effectiveness analyses should not be arbitrarily selected. We describe 3 methods to ensure that enough parameter samples are used in probabilistic cost-effectiveness analyses.
引用
收藏
页码:1553 / 1563
页数:11
相关论文
共 50 条
  • [1] Monte Carlo simulation of cost-effectiveness ratios
    Filho, JAF
    Calil, SJ
    PROCEEDINGS OF THE 22ND ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOLS 1-4, 2000, 22 : 595 - 598
  • [2] Use of Number Needed to Treat in Cost-Effectiveness Analyses
    Garg, Vishvas
    Shen, Xian
    Cheng, Yan
    Nawarskas, James J.
    Raisch, Dennis W.
    ANNALS OF PHARMACOTHERAPY, 2013, 47 (03) : 380 - 387
  • [3] Cost-effectiveness of adding Sativex® spray to spasticity care in Belgium: using bootstrapping instead of Monte Carlo simulation for probabilistic sensitivity analyses
    Mark Oppe
    Daniela Ortín-Sulbarán
    Carlos Vila Silván
    Anabel Estévez-Carrillo
    Juan M. Ramos-Goñi
    The European Journal of Health Economics, 2021, 22 : 711 - 721
  • [4] Cost-effectiveness of adding Sativex® spray to spasticity care in Belgium: using bootstrapping instead of Monte Carlo simulation for probabilistic sensitivity analyses
    Oppe, Mark
    Ortin-Sulbaran, Daniela
    Vila Silvan, Carlos
    Estevez-Carrillo, Anabel
    Ramos-Goni, Juan M.
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2021, 22 (05): : 711 - 721
  • [5] Prostate biopsies: How many samples and how many containers? Cost effectiveness
    Molinie, Vincent
    Mahjoub, Wafa K.
    Balaton, Andre
    ANNALES DE PATHOLOGIE, 2008, 28 (05) : 424 - 428
  • [6] COST-EFFECTIVENESS ANALYSES
    STEINBERG, EP
    NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (02): : 123 - 123
  • [7] AMBULATORY ELECTROCARDIOGRAPHIC MONITORING IN PATIENTS WITH SYNCOPE - PROBABILISTIC AND COST-EFFECTIVENESS ANALYSES
    BECK, JR
    SALEM, DN
    PAUKER, SG
    CLINICAL RESEARCH, 1983, 31 (02): : A293 - A293
  • [8] Probabilistic measures of cost-effectiveness
    Bebu, Ionut
    Mathew, Thomas
    Lachin, John M.
    STATISTICS IN MEDICINE, 2016, 35 (22) : 3976 - 3986
  • [9] Cost and cost-effectiveness: Consistent terminology is needed
    Marshall, JK
    O'Brien, BJ
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 1999, 94 (04): : 1108 - 1109
  • [10] The "e" In Cost-Effectiveness Analyses: Efficacy Or Effectiveness Of Asthma Medications Used In Cost-Effectiveness Analyses?
    Dilokthornsakul, P.
    Chaiyakunapruk, N.
    Campbell, J. D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191